Conmed Corp
Research Conmed Corp (CNMD) on Bullrun: valuation model: 10.2% overvalued, market cap USD 1.33B, P/E 24.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCNMD
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal10.2% overvalued
- Market capUSD 1.33B
- P/E24.0
- Financial periodQ2 2026
- RevenueUSD 343.49M
- Net incomeUSD 23.07M
- Free cash flowUSD 34.16M
- Gross margin57.5%
Valuation Snapshot
Bullrun's latest valuation model marks Conmed Corp as 10.2% overvalued; latest market cap is USD 1.33B; P/E is 24.0.
Peer valuation comparison
Latest P/E is 24.02x versus a Healthcare sector median of 24.61x (2.4% below).
Latest P/E is 24.02x versus a United States median of 23.85x.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.37B | USD 47.10M | USD 150.88M | 54.6% | 1.51 | USD 40.82M | USD 834.94M | USD 1.03B |
| FY2024 | USD 1.31B | USD 132.40M | USD 153.88M | 56.1% | 4.25 | USD 24.46M | USD 905.78M | USD 962.68M |
| FY2023 | USD 1.24B | USD 64.50M | USD 106.32M | 54.3% | 2.04 | USD 24.30M | USD 973.85M | USD 834.22M |
| FY2022 | USD 1.05B | -USD 80.60M | USD 11.58M | 54.6% | -2.68 | USD 28.94M | USD 1.05B | USD 745.55M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 1.33B | 24.0 | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.26B | 26.7 | 1.5% | 0.6 |
| 2024 | 2024-12-31 | USD 2.11B | 16.1 | 1.2% | 0.8 |
| 2023 | 2023-12-29 | USD 3.37B | 59.2 | 0.7% | 0.8 |
| 2022 | 2022-12-30 | USD 2.70B | n/a | 0.9% | 0.8 |
| 2021 | 2021-12-31 | USD 4.16B | 73.5 | 0.6% | 0.8 |
Dividend history
| Year | Dividends/share |
|---|---|
| FY2025 | 0.6 USD |
| FY2024 | 0.8 USD |
| FY2023 | 0.8 USD |
| FY2022 | 0.8 USD |
About Conmed Corp
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Conmed Corp overvalued or undervalued?
Bullrun's valuation model currently marks Conmed Corp as 10.2% overvalued.
What is Conmed Corp's market cap?
Conmed Corp's market capitalization is USD 1.33B.
What is Conmed Corp's P/E ratio?
Conmed Corp's price-to-earnings (P/E) ratio is 24.0.
What does Conmed Corp do?
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.